Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
US Army
US Department of Justice
Chubb
Queensland Health
Argus Health
Dow
Medtronic
Cerilliant

Generated: December 11, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0300531.1

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-001Jun 30, 2011RXYesNo► Subscribe► Subscribe► SubscribeY
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-002Jun 30, 2011RXYesYes► Subscribe► Subscribe► SubscribeY
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-001Jun 30, 2011RXYesNo► Subscribe► Subscribe► SubscribeMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-002Jun 30, 2011RXYesYes► Subscribe► Subscribe► SubscribeMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-001Jun 30, 2011RXYesNo► Subscribe► Subscribe► SubscribeMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-002Jun 30, 2011RXYesYes► Subscribe► Subscribe► SubscribeMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist